Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictmedix Ai Inc (CSE: PMED )

0.0450 +0.0100 (+28.57%)
Official Closing Price Updated: 3:54 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 675,694
Open 0.0350
Bid (Size) 0.0350 (836,000)
Ask (Size) 0.0450 (76,000)
Prev. Close 0.0350
Today's Range 0.0350 - 0.0450
52wk Range 0.0050 - 0.0750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Predictmedix AI Expands Reach and Impact in Healthcare Transformation Efforts
Via ACCESSWIRE
Predictmedix AI Expands Strategic Partnerships with Samyak Solutions Inc. and Manchester Marketing Group Inc. for Safe Entry Distribution in the US Market
Via ACCESSWIRE

Performance

YTD
+350.00%
+350.00%
1 Month
+125.00%
+125.00%
3 Month
+200.00%
+200.00%
6 Month
+350.00%
+350.00%
1 Year
-35.71%
-35.71%

More News

Read More
Predictmedix AI and UVTV Digital India Forge Strategic Partnership to Revolutionize Health and Safety in Sports and Worship Venues
Via ACCESSWIRE
Predictmedix AI and KGK Science Partner to Enhance Health Research and Product Development
Via ACCESSWIRE
Predictmedix AI Rolls Out Advanced AI-Powered Safe Entry Stations at Trinity Hospital
Via ACCESSWIRE
Predictmedix AI and Digital Medical Experts Forge Transformative Alliance in Mental Health
Via ACCESSWIRE
Predictmedix AI Unveils Technological Advances Including Publishing of Peer-Reviewed Paper
Via ACCESSWIRE
Predictmedix AI Elevates Safe Entry Stations with Cutting-Edge Facial Recognition Technology
Via ACCESSWIRE
The Telehealth Revolution: 3 Stocks Leading the Charge
Via InvestorPlace
Topics Economy
Exposures Economy
Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis
Via ACCESSWIRE
Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection
Via ACCESSWIRE
Predictmedix AI Showcases Innovative Impairment Screening Technology at a 30-Country Summit in India, Focusing on Combating Drug Addiction Globally
Via ACCESSWIRE
Predictmedix AI Accelerates Corporate Expansion During Month-Long International Campaign
Via ACCESSWIRE
Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
Via ACCESSWIRE
Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
Via ACCESSWIRE
Predictmedix AI's 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion
Via ACCESSWIRE
Predictmedix AI Expands Diagnostic Reach in India with Innovative Diabetes Non-Invasive Screening
Via ACCESSWIRE
Enhancing Healthcare Economics: Predictmedix AI's Safe Entry Stations Revolutionize Safety and Efficiency
Via ACCESSWIRE
Predictmedix AI Announces Milestone of Over 200,000 Individual Scans with AI-Powered Safe Entry Station
Via ACCESSWIRE
Predictmedix AI Provides Update on Commercialization of Safe Entry with the Indonesian Healthcare Sector
Via ACCESSWIRE
Predictmedix AI Engages in Partnership with Indian Supplier for Mass Production and Rapid Deployment of Safe Entry Stations
Via ACCESSWIRE
Predictmedix AI Unveils Cutting-Edge Contactless Integrative AI Solutions for Healthcare in India and Incorporates Fully Owned Indian Subsidiary
Via ACCESSWIRE
Predictmedix Inc. Announces Name Change to Predictmedix AI Inc.
Via ACCESSWIRE
Predictmedix Announces Proposed Name Change to Predictmedix AI, Reflecting AI-driven Solutions for Healthcare, Workplace Safety, Impairment Detection, and Fitness Screening
Via ACCESSWIRE
Predictmedix Announces Closing of Private Placement
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.